BTIG Starts Galera Therapeutics (GRTX) at Buy, Street High PT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
BofA/Merrill Lynch Starts Galera Therapeutics (GRTX) at Buy
December 2, 2019 6:05 AM ESTBofA/Merrill Lynch initiates coverage on Galera Therapeutics (NASDAQ: GRTX) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Galera Therapeutics click here. For more ratings news on Galera Therapeutics click here.
Shares of Galera Therapeutics closed at $12.53 yesterday.
... MoreCiti Starts Galera Therapeutics (GRTX) at Buy
December 2, 2019 5:27 AM ESTCiti analyst Yigal Nochomovitz initiates coverage on Galera Therapeutics (NASDAQ: GRTX) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Galera Therapeutics click here. For more ratings news on Galera Therapeutics click here.
Shares of Galera Therapeutics closed at $12.53 yesterday.
... More